| Q37454165 | A disseminated infection with the antifungal-multiresistant teleomorphic fungus Neocosmospora vasinfecta in a patient with acute B-lymphoblastic leukemia |
| Q42203400 | A long-term survivor of disseminated Aspergillus and mucorales infection: an instructive case |
| Q64240072 | A novel diagnosis scoring model to predict invasive pulmonary aspergillosis in the intensive care unit |
| Q37077782 | Aspergillus-associated airway disease, inflammation, and the innate immune response |
| Q92156299 | Blood culture and antimicrobial susceptibility pattern of bacteria and fungi isolated from febrile neutropenic patients treated with chemotherapy at Taleghani hospital, Tehran |
| Q40562624 | Breakthrough invasive fungal diseases during voriconazole treatment for aspergillosis: A 5-year retrospective cohort study |
| Q41969829 | Case report: Enteral nutritional supplement as a likely cause of false-positive galactomannan testing |
| Q35300180 | Cerebral aspergillosis in a patient with leprosy and diabetes: a case report |
| Q37373785 | Concurrent lung infections in patients with hematological malignancies and invasive pulmonary aspergillosis: how firm is the Aspergillus diagnosis? |
| Q38221673 | Current challenges in the microbiological diagnosis of invasive aspergillosis |
| Q37317965 | Development and evaluation of enzyme-linked immunosorbent assay of nucleic acid sequence-based amplification for diagnosis of invasive aspergillosis |
| Q30608976 | Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). |
| Q26795425 | Diagnosis of Fusarium Infections: Approaches to Identification by the Clinical Mycology Laboratory |
| Q37437204 | Disseminated Fusarium infection in a patient with acute lymphoblastic leukemia: A case report and review of the literature |
| Q38667725 | Disseminated fusariosis by Fusarium proliferatum in a patient with aplastic anaemia receiving primary posaconazole prophylaxis - case report and review of the literature |
| Q64075702 | Disseminated fusariosis with ecthyma gangrenosum-like lesions in a refractory acute myeloid leukemia patient |
| Q31149815 | Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing |
| Q41846501 | Ecthyma Gangrenosum-like Lesions in a Febrile Neutropenic Patient with Simultaneous Pseudomonas Sepsis and Disseminated Fusariosis |
| Q42272283 | Emerging fungal infections in solid organ transplantation |
| Q38308558 | Exonuclease I aided enzyme-linked aptamer assay for small-molecule detection |
| Q38626372 | Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature |
| Q40215030 | Fatal breakthrough infection with Fusarium andiyazi: new multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay |
| Q38128235 | Fusariosis, a complex infection caused by a high diversity of fungal species refractory to treatment. |
| Q40061239 | Galactofuranose antigens, a target for diagnosis of fungal infections in humans |
| Q42838532 | Graphium basitruncatum fungemia in an immunosuppressed child post stem-cell transplantation. |
| Q38686517 | How to manage lung infiltrates in adults suffering from haematological malignancies outside allogeneic haematopoietic stem cell transplantation |
| Q34158642 | Immunoproteome of Aspergillus fumigatus using sera of patients with invasive aspergillosis |
| Q35757673 | Improved Standardization of the Bio-Rad Platelia Aspergillus Galactomannan Antigen Sandwich Enzyme Immunoassay Using the DS2 (Dynex) Enzyme-Linked Immunosorbent Assay (ELISA) Processing System |
| Q37544662 | Incidence density of invasive fungal infections during primary antifungal prophylaxis in newly diagnosed acute myeloid leukemia patients in a tertiary cancer center, 2009 to 2011 |
| Q57111571 | Intracatheter Antifungal Lock Leading to Detrimental Complications |
| Q40722341 | Invasive mould sinusitis in patients with haematological malignancies: a 10 year single-centre study |
| Q58418132 | Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach |
| Q38675812 | Invasive pulmonary mycosis due to Chaetomium globosum with false-positive galactomannan test: a case report and literature review |
| Q37287794 | Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome |
| Q38227595 | Mold infections of the central nervous system |
| Q34057660 | Molecular and nonmolecular diagnostic methods for invasive fungal infections |
| Q36218994 | Molecular diagnosis of invasive mycoses of the central nervous system |
| Q92408865 | Monoclonal Antibody AP3 Binds Galactomannan Antigens Displayed by the Pathogens Aspergillus flavus, A. fumigatus, and A. parasiticus |
| Q50195666 | Necrotizing fungal gingivitis in a patient with Acute Myelogenous Leukemia: visible yet obscure |
| Q38266817 | Non-cultural methods for the diagnosis of invasive fungal disease |
| Q39144117 | Nucleic acid amplification methodologies for the detection of pulmonary mold infections |
| Q33736249 | Penicillium citrinum: Opportunistic pathogen or idle bystander? A case analysis with demonstration of galactomannan cross-reactivity. |
| Q26827758 | Pneumonia in the neutropenic cancer patient |
| Q34532546 | Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America |
| Q39127825 | Prognostic value of galactomannan: current evidence for monitoring response to antifungal therapy in patients with invasive aspergillosis |
| Q34565293 | Prolyl endopeptidase activity in bronchoalveolar lavage fluid: a novel diagnostic biomarker in a guinea pig model of invasive pulmonary aspergillosis |
| Q40258864 | Serum galactomannan assay for the diagnosis of invasive aspergillosis in children with haematological malignancies |
| Q39189670 | The current treatment landscape: other fungal diseases (cryptococcosis, fusariosis and mucormycosis). |
| Q38508539 | The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients |
| Q38221405 | Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry |
| Q38116964 | Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis |